胶原蛋白“退烧”:巨子、锦波互侵腹地,近10家A股企业入局

21世纪经济报道
Nov 12, 2025

21世纪经济报道记者凌晨报道  2025年双十一落幕,胶原蛋白市场凉意凸显。  风向的转变,往往始于细微处。可复美GMV的同比下滑,行业龙头巨子生物与锦波生物增长步伐的放缓……这个曾经被资本与市场共同追捧的“成分明星”,似乎正迎来自己的冷静期。  更为直接的信号,来自于市场本身的收缩。华熙生物旗下胶原蛋白品牌“润熙泉”,在多个平台的官方店铺已悄然清空;而上美股份旗下曾专注于该领域的“胶原丽”,也已...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10